-
CSCO Journey │ Professor Man Li: CSCO Member No. 168, Witness to China’s Leap Forward in Clinical Oncology
Q1. Growth with CSCO and Its Influence Prof. Man Li: I started working in 1996 and became a member of the CSCO family in 1997. My membership number is 19970168—quite…
-
Professor Fei Ma: Ushering in a New Era of ‘Chemotherapy + Immunotherapy + Targeted Therapy’ for Advanced Triple-Negative Breast Cancer
Q1. The Synergy of Chemotherapy, Immunotherapy, and Targeted Therapy Prof. Fei Ma: Triple-negative breast cancer is a subtype of breast cancer, accounting for about 15% of all cases. Among them,…
-
ISEH 2025 China–Japan Dialogue | Prof. Jianxiang Wang and Prof. Naoki Hosen: Direct Insights into CAR-T Therapy for Leukemia and a New Blueprint for International Collaboration
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held in Kumamoto, Japan, from September 24–27. The conference brought together leading experts in hematology from around the world to discuss cutting-edge progress in basic hematology, immunology, stem cell research, and cell and gene therapies. During the meeting, Oncology Frontier…
Connecting Medical Expertise through Media